Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules-Reference-Cited by-同舟云学术

Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules

Published:2011-04-01 Issue:4 Volume:6 Page:e17665
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hultberg Anna,Temperton Nigel J.,Rosseels Valérie,Koenders Mireille,Gonzalez-Pajuelo Maria,Schepens Bert,Ibañez Lorena Itatí,Vanlandschoot Peter,Schillemans Joris,Saunders Michael,Weiss Robin A.,Saelens Xavier,Melero José A.,Verrips C. Theo,Van Gucht Steven,de Haard Hans J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. New antivirals and drug resistance.;PM Colman;Annu Rev Biochem,2009

2. Hepatitis B virus escape mutants induced by antiviral therapy.;J Sheldon;J Antimicrob Chemother,2008

3. Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.;A Forsman;J Virol,2008

4. Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.;L Garaicoechea;J Virol,2008

5. Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments.;JM van der Vaart;Vaccine,2006

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. H1N1 nanobody development and therapeutic efficacy verification in H1N1-challenged mice;Biomedicine & Pharmacotherapy;2024-07

2. Phage display technology and its impact in the discovery of novel protein-based drugs;Expert Opinion on Drug Discovery;2024-06-18

3. Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons;World Journal of Microbiology and Biotechnology;2024-05-21

4. Single domain antibodies from camelids in the treatment of microbial infections;Frontiers in Immunology;2024-05-17

5. Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus;Acta Naturae;2024-05-10